Michal Cohen1,2, Rebecca Persky3, Rachel Stegemann4, Laura C Hernández-Ramírez3, Deena Zeltser3, Maya B Lodish3, Anlu Chen5, Margaret F Keil3, Christina Tatsi3, Fabio R Faucz3, David A Buchner4,5,6, Constantine A Stratakis3, Dov Tiosano1,2. 1. Pediatric Endocrinology Unit, Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Haifa, Israel. 2. The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel. 3. Section on Genetics and Endocrinology, Intramural Research Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland. 4. Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, Ohio. 5. Department of Biochemistry, Case Western Reserve University, Cleveland, Ohio. 6. Research Institute for Children's Health, Case Western Reserve University, Cleveland, Ohio.
Abstract
BACKGROUND: Somatic mutations in the ubiquitin-specific peptidase 8 (USP8) gene are common in corticotropinomas of children with Cushing disease (CD). We report a unique patient with a germline USP8 mutation who presented with CD and a constellation of other findings that constitute an intriguing genetic syndrome. CASE DESCRIPTION: We describe a 16-year-old female with CD, developmental delay, dysmorphic features, ichthyosiform hyperkeratosis, chronic lung disease, chronic kidney disease, hyperglycemia, dilated cardiomyopathy with congestive heart failure, and previous history of hyperinsulinism and partial GH deficiency. She was diagnosed with CD at 14 years old and underwent transsphenoidal surgery. Despite initial improvement, she developed recurrent CD. METHODS: DNA was extracted from peripheral blood and tumor DNA; whole-exome and Sanger confirmatory sequencing were performed. Immunohistochemistry was performed on the resected adenoma. RESULTS: A de novo germline heterozygous USP8 mutation (c.2155T>C, p.S719P) in the critical 14-3-3 binding motif hot spot locus of the gene was identified in both the peripheral blood and tumor DNA. Histopathologic evaluation of the resected tumor confirmed an ACTH-secreting adenoma. CONCLUSION: Somatic USP8 mutations are common in adenomas causing CD, but to date, no germline defects have been reported. We describe a patient with a de novo germline USP8 mutation with recurrent CD and multiple other medical problems. This unique patient informs us of the multitude of signaling events that may be controlled by USP8. Published by Oxford University Press on behalf of the Endocrine Society 2019.
BACKGROUND: Somatic mutations in the ubiquitin-specific peptidase 8 (USP8) gene are common in corticotropinomas of children with Cushing disease (CD). We report a unique patient with a germline USP8 mutation who presented with CD and a constellation of other findings that constitute an intriguing genetic syndrome. CASE DESCRIPTION: We describe a 16-year-old female with CD, developmental delay, dysmorphic features, ichthyosiform hyperkeratosis, chronic lung disease, chronic kidney disease, hyperglycemia, dilated cardiomyopathy with congestive heart failure, and previous history of hyperinsulinism and partial GH deficiency. She was diagnosed with CD at 14 years old and underwent transsphenoidal surgery. Despite initial improvement, she developed recurrent CD. METHODS: DNA was extracted from peripheral blood and tumor DNA; whole-exome and Sanger confirmatory sequencing were performed. Immunohistochemistry was performed on the resected adenoma. RESULTS: A de novo germline heterozygous USP8 mutation (c.2155T>C, p.S719P) in the critical 14-3-3 binding motif hot spot locus of the gene was identified in both the peripheral blood and tumor DNA. Histopathologic evaluation of the resected tumor confirmed an ACTH-secreting adenoma. CONCLUSION: Somatic USP8 mutations are common in adenomas causing CD, but to date, no germline defects have been reported. We describe a patient with a de novo germline USP8 mutation with recurrent CD and multiple other medical problems. This unique patient informs us of the multitude of signaling events that may be controlled by USP8. Published by Oxford University Press on behalf of the Endocrine Society 2019.
Authors: J Lindholm; S Juul; J O Jørgensen; J Astrup; P Bjerre; U Feldt-Rasmussen; C Hagen; J Jørgensen; M Kosteljanetz; L Kristensen; P Laurberg; K Schmidt; J Weeke Journal: J Clin Endocrinol Metab Date: 2001-01 Impact factor: 5.958
Authors: Anlu Chen; Dov Tiosano; Tulay Guran; Hagit N Baris; Yavuz Bayram; Adi Mory; Laura Shapiro-Kulnane; Craig A Hodges; Zeynep C Akdemir; Serap Turan; Shalini N Jhangiani; Focco van den Akker; Charles L Hoppel; Helen K Salz; James R Lupski; David A Buchner Journal: Hum Mol Genet Date: 2018-06-01 Impact factor: 6.150
Authors: Leanne de Kock; Nelly Sabbaghian; François Plourde; Archana Srivastava; Evan Weber; Dorothée Bouron-Dal Soglio; Nancy Hamel; Joon Hyuk Choi; Sung-Hye Park; Cheri L Deal; Megan M Kelsey; Megan K Dishop; Adam Esbenshade; John F Kuttesch; Thomas S Jacques; Arie Perry; Heinz Leichter; Philippe Maeder; Marie-Anne Brundler; Justin Warner; James Neal; Margaret Zacharin; Márta Korbonits; Trevor Cole; Heidi Traunecker; Thomas W McLean; Fabio Rotondo; Pierre Lepage; Steffen Albrecht; Eva Horvath; Kalman Kovacs; John R Priest; William D Foulkes Journal: Acta Neuropathol Date: 2014-05-20 Impact factor: 17.088
Authors: Laura C Hernández-Ramírez; Ryhem Gam; Nuria Valdés; Maya B Lodish; Nathan Pankratz; Aurelio Balsalobre; Yves Gauthier; Fabio R Faucz; Giampaolo Trivellin; Prashant Chittiboina; John Lane; Denise M Kay; Aggeliki Dimopoulos; Stephan Gaillard; Mario Neou; Jérôme Bertherat; Guillaume Assié; Chiara Villa; James L Mills; Jacques Drouin; Constantine A Stratakis Journal: Endocr Relat Cancer Date: 2017-05-22 Impact factor: 5.678
Authors: Fabio R Faucz; Amit Tirosh; Christina Tatsi; Annabel Berthon; Laura C Hernández-Ramírez; Nikolaos Settas; Anna Angelousi; Ricardo Correa; Georgios Z Papadakis; Prashant Chittiboina; Martha Quezado; Nathan Pankratz; John Lane; Aggeliki Dimopoulos; James L Mills; Maya Lodish; Constantine A Stratakis Journal: J Clin Endocrinol Metab Date: 2017-08-01 Impact factor: 5.958
Authors: Laura C Hernández-Ramírez; Christina Tatsi; Maya B Lodish; Fabio R Faucz; Nathan Pankratz; Prashant Chittiboina; John Lane; Denise M Kay; Nuria Valdés; Aggeliki Dimopoulos; James L Mills; Constantine A Stratakis Journal: J Endocr Soc Date: 2017-05-30
Authors: Sunita M C De Sousa; Paul P S Wang; Stephen Santoreneos; Angeline Shen; Christopher J Yates; Milena Babic; Leila Eshraghi; Jinghua Feng; Barbara Koszyca; Samuel Roberts-Thomson; Andreas W Schreiber; David J Torpy; Hamish S Scott Journal: Endocr Pathol Date: 2019-12 Impact factor: 3.943
Authors: Michal Cohen; Rebecca Persky; Rachel Stegemann; Laura C Hernández-Ramírez; Deena Zeltser; Maya B Lodish; Anlu Chen; Margaret F Keil; Christina Tatsi; Fabio R Faucz; David A Buchner; Constantine A Stratakis; Dov Tiosano Journal: J Clin Endocrinol Metab Date: 2019-10-01 Impact factor: 5.958
Authors: Pietro Locantore; Rosa Maria Paragliola; Gianluca Cera; Roberto Novizio; Ettore Maggio; Vittoria Ramunno; Andrea Corsello; Salvatore Maria Corsello Journal: Int J Mol Sci Date: 2022-06-19 Impact factor: 6.208
Authors: Fanny Chasseloup; Nathan Pankratz; John Lane; Fabio R Faucz; Margaret F Keil; Prashant Chittiboina; Denise M Kay; Tara Hussein Tayeb; Constantine A Stratakis; James L Mills; Laura C Hernández-Ramírez Journal: J Clin Endocrinol Metab Date: 2020-06-01 Impact factor: 5.958
Authors: Idoia Martínez de LaPiscina; Laura C Hernández-Ramírez; Nancy Portillo; Ana L Gómez-Gila; Inés Urrutia; Rosa Martínez-Salazar; Alejandro García-Castaño; Aníbal Aguayo; Itxaso Rica; Sonia Gaztambide; Fabio R Faucz; Margaret F Keil; Maya B Lodish; Martha Quezado; Nathan Pankratz; Prashant Chittiboina; John Lane; Denise M Kay; James L Mills; Luis Castaño; Constantine A Stratakis Journal: Front Endocrinol (Lausanne) Date: 2020-07-03 Impact factor: 5.555